CRISPR technology can correct Alpha-1 antitrypsin deficiency
Groundbreaking research demonstrates proof-of-concept for using CRISPR-Cas9 genome editing technology to correct the gene mutation responsible for AAT deficiency...
List view / Grid view
Groundbreaking research demonstrates proof-of-concept for using CRISPR-Cas9 genome editing technology to correct the gene mutation responsible for AAT deficiency...
Therapeutic use of gene editing with the so-called CRISPR-Cas9 technique may inadvertently increase the risk of cancer...
Progress in stem cell research and its translation to medicine is the focus of the International Society for Stem Cell Research annual meeting 20-23 June at the Melbourne Convention & Exhibition Centre in Melbourne, Australia.
A study reveals why people with the APOE4 gene have a higher risk of the disease...
New study uses CRISPR/Cas9 to make CD33 CAR T cells cancer-specific...
Researchers have developed a small-molecule-based tool that acts on RNA to selectively delete certain gene products...
By destroying the regulatory genes of the AIDS virus HIV-1 using the genome editing system CRISPR/Cas9, researchers have succeeded in blocking the production of HIV-1 by infected cells...
Scientists have generated an atlas of the human genome using a state-of-the-art gene editing technology and human embryonic stem cells, illuminating the roles that our genes play in health and disease.
In this application note, BMG Labtech discuss how the Bioluminescence resonance energy transfer (BRET) is a versatile tool to study interactions and trafficking in proteins.
Study provides a roadmap for using CRISPR to investigate neurological disorders...
Somatic Cell Genome Editing aims to develop tools for safe and effective genome editing in humans...
Newly described stretches of super-silenced DNA reveal a fresh approach to reprogram cell identity.
An international team of researchers have developed 3D cell cultures in which genes can be specifically modified to improve the use of targeted anti-cancer drugs...
Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to become abnormal...
New 'REPAIR' system edits RNA, rather than DNA, without permanently affecting the genome...